APS
30th APS Annual Convention · 2018
Neuropsychological Prediction of Treatment Response to Ketamine in Patients with Suicidal Ideation and Major Depression
- Sean Madden
Columbia University Department of Psychiatry - Sean Madden
New York State Psychiatric Institute - John Keilp
Columbia University Vagelos College of Physicians and Surgeons - John Keilp
New York State Psychiatric Institute - Michael Grunebaum
Columbia University Department of Psychiatry - Michael Grunebaum
New York State Psychiatric Institute - Julia Marver
Columbia University Department of Psychiatry - Julia Marver
New York State Psychiatric Institute - Michelle Parris
Columbia University Department of Psychiatry - Michelle Parris
New York State Psychiatric Institute - Maria Oquendo
University of Pennsylvania Perelman School of Medicine - J. Mann
Columbia University Department of Psychiatry - J. Mann
New York State Psychiatric Institute
Abstract
Seventy-eight depressed patients with elevated suicidal ideation receiving ketamine vs. midazolam infusion as an antidepressant treatment completed neuropsychological assessments. Better baseline memory performance predicted ketamine antidepressant response, contrasting with previous studies; less implicit association to suicide and lower risk taking were associated with reductions in suicidal thinking.
Depression